Abstract: An antiglaucoma composition containing as the active component a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride of the general formula: ##STR1## where R.sub.1 .dbd.R.sub.2 .dbd.R.sub.3 .dbd.R.sub.4 .dbd.H.dbd.R.sub.5 .dbd.R.sub.6 .dbd.R.sub.7 .dbd.CH.sub.3 OThe composition is used as an ophthalmic solution in a method for treating glaucoma by administering a therapeutic dose of 2 to 3 drops two to four times daily to a host such as a warm-blooded animal having glaucoma.
Type:
Grant
Filed:
March 3, 1988
Date of Patent:
May 8, 1990
Assignee:
Pharmachim
Inventors:
Marko T. Markov, Chavdar B. Ivanov, Deltcho G. Jelyazkov, Diana M. Mondeschka, Nikolina D. Berova, Rositza S. Rakovska, Maria G. Todorova, Diana D. Popova, Emiliya D. Slavova, Tatyana S. Zikolova, Viola M. Marinova, Radi G. Ovcharov, Petko D. Uzunov, Jossif N. Nissimov, Dobrinka G. Gentcheva